Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
about
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancerEpigenetic alterations of the Wnt signaling pathway in cancer: a mini reviewRecent progress in the study of methylated tumor suppressor genes in gastric cancerRole of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature reviewDiagnostic role of Wnt pathway gene promoter methylation in non small cell lung cancerDickkopf-related protein 2 induces G0/G1 arrest and apoptosis through suppressing Wnt/β-catenin signaling and is frequently methylated in breast cancer.The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors.Epigenetic silencing of the WNT antagonist Dickkopf 3 disrupts normal Wnt/β-catenin signalling and apoptosis regulation in breast cancer cellsMethylation-mediated gene silencing as biomarkers of gastric cancer: a review.Overexpression of Dickkopf-3 induces apoptosis through mitochondrial pathway in human colon cancerGenomic and genetic alterations influence the progression of gastric cancer.Promoter methylation analysis of WNT/β-catenin pathway regulators and its association with expression of DNMT1 enzyme in colorectal cancer.DNA methylation predicts recurrence from resected stage III proximal colon cancer.Plasma DNA methylation of Wnt antagonists predicts recurrence of esophageal squamous cell carcinoma.MALDI-TOF Mass Array Analysis of Nell-1 Promoter Methylation Patterns in Human Gastric CancerClinical Significance of MLH1 Methylation and CpG Island Methylator Phenotype as Prognostic Markers in Patients with Gastric Cancer.Methylation-dependent activation of CDX1 through NF-κB: a link from inflammation to intestinal metaplasia in the human stomach.Systematic CpG islands methylation profiling of genes in the wnt pathway in epithelial ovarian cancer identifies biomarkers of progression-free survival.The roles of BTG3 expression in gastric cancer: a potential marker for carcinogenesis and a target molecule for gene therapy.A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis.CpG island hypermethylation in gastric carcinoma and its premalignant lesions.Glycogen Synthase Kinase 3 Beta Predicts Survival in Resected Adenocarcinoma of the PancreasTelomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer.Dapper homolog 1 is a novel tumor suppressor in gastric cancer through inhibiting the nuclear factor-κB signaling pathway.Single nucleotide polymorphisms in DKK3 gene are associated with prostate cancer risk and progressionDeregulation of Wnt/β-catenin signaling through genetic or epigenetic alterations in human neuroendocrine tumors.Expression of the Wnt antagonist Dickkopf-3 is associated with prognostic clinicopathologic characteristics and impairs proliferation and invasion in endometrial cancer.Gastric cancer and related epigenetic alterations.Concurrent Hypermethylation of SFRP2 and DKK2 Activates the Wnt/β-Catenin Pathway and Is Associated with Poor Prognosis in Patients with Gastric Cancer.Defining the cancer master switch.Epigenetic biomarkers in colorectal cancer diagnostics.Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer.Epigenetic biomarkers: potential applications in gastrointestinal cancersDysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma.Epigenetics in gastric carcinogenesis: TET genes as important players.Novel biomarkers for the identification and targeted therapy of gastric cancer.A global burden of gastric cancer: the major impact of China.Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers.Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance.Targeting the Wnt pathway in synovial sarcoma models.
P2860
Q21260388-10622DDE-2B5A-431E-8B22-55F797801591Q26824835-F1DCA73D-AFE2-40B8-B8F1-12E9FBFDC075Q27009359-A2DB2732-F8EC-4C6F-AF9D-6A30E1A6597DQ28086989-98877CA8-3BCD-4F1B-90D9-1E591715A17DQ33829495-BA820A5B-42B5-49C7-AF2D-B13C9728630DQ33889229-44A1BCB3-4119-472C-AB74-40DDCDE98217Q34075626-8F5041C9-BFA7-4284-AEBB-34C98CF3FDBDQ34154767-AFB73B16-A2F8-40A4-A915-717DA770B470Q34168437-1C58604B-8DDA-4C1F-8B09-E2E3091EB813Q34243489-0E6AE981-51C2-4EBE-932F-C62BEA7B3166Q34497423-F78512EF-7087-4680-9F46-D71F20CFD7AEQ34544597-51A282ED-E5B0-415C-870D-93F67309D044Q35051119-3F016043-2EA2-4577-85FC-9843972ED952Q35606943-3238F4C7-02AF-4F9A-94B4-334AE5EC7BE7Q35668216-4F85FA85-FA7C-4E81-9D27-6ABE5BCA96B5Q35677409-27339B3B-401B-418B-8914-278D96914E43Q36131557-CA67CCCE-BC1D-4728-B518-D59F293CAC59Q36201267-ADEA8120-DAED-4803-8B93-0D120BEB26E8Q36260657-80F38F1E-3A46-42B3-A416-61F629A49AE5Q36294469-D169CE1E-C661-46BC-A0CF-F81694976956Q36343388-E4E5F8A1-4B71-4BF9-B7FD-D8428D4B2377Q36378003-2D866332-C9BD-4BE2-8F5E-C9A5C4931B78Q36473614-85502829-F8FB-4DD9-85F4-3DE37F78BC87Q36498313-266CB8E6-D6B8-4E85-A5BA-C7064B25A8B8Q36589284-FB3E4E65-9597-47F6-941C-C5DC66197329Q36813981-4A667952-22AC-4FE4-AC02-EB8F826CD5DAQ36944293-5281CC28-1E2E-4855-8EA8-2DC8FB0DF43DQ37592416-5B5EB522-261A-4F4F-8331-1A8AD42AFAE7Q37637877-FA608E02-434C-41F1-8853-7E7F0F64CC53Q37834359-9F1DD88F-B6AD-4527-9002-60008F20363BQ38018997-F344A10D-5DF8-456B-B90A-373291A1D6F6Q38115621-340BFC21-9BB3-4797-A753-D2F6847860B4Q38204377-B235E90E-DC2E-4C9B-9B4D-4267966BA840Q38210247-ABB29298-B009-461E-B6E1-B28B26D5A665Q38365055-16CF8D26-3827-46F5-970B-11807C195AA7Q38556435-60E7461A-D3F8-498E-90DE-8F1AF0F3C04CQ38738402-FC26A920-2681-4992-BA89-FB478C3D2048Q38751688-5FDEFEDA-9DF2-42B9-B5F4-B2B7BD3936BBQ38807957-8ADD0B2B-CCBC-4C6A-9A9D-30172AF8FF6CQ39114461-03C3F937-0900-4BA7-B532-EB0B7B13D0F1
P2860
Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Promoter methylation of the Wn ...... or survival in gastric cancer.
@en
Promoter methylation of the Wn ...... or survival in gastric cancer.
@nl
type
label
Promoter methylation of the Wn ...... or survival in gastric cancer.
@en
Promoter methylation of the Wn ...... or survival in gastric cancer.
@nl
prefLabel
Promoter methylation of the Wn ...... or survival in gastric cancer.
@en
Promoter methylation of the Wn ...... or survival in gastric cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Promoter methylation of the Wn ...... or survival in gastric cancer.
@en
P2093
Francis K L Chan
Kin F Cheung
Kwan Y Lee
Linwei Tian
Matthias P A Ebert
Simon S M Ng
Ulf Neumann
Yuen Y Cheng
P2860
P356
10.1002/CNCR.23989
P407
P577
2009-01-01T00:00:00Z